Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Clapper, JR"'
Autor:
Sanchini, Silvano, Duranti, Andrea, Tontini, Andrea, Tarzia, Giorgio, Lodola, A, Rivara, S, Vacondio, F, Mor, M, Clapper, Jr, MORENO SANZ, G, Piomelli, D.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3656::4f37e034b26cce7e8853b3cb63a90d17
https://hdl.handle.net/11576/2503634
https://hdl.handle.net/11576/2503634
Autor:
Mor, M, Lodola, A, Rivara, S, Vacondio, F, Duranti, A, Tontini, A, Sanchini, S, Piersanti, G, Clapper, JR, King, AR, Tarzia, G, Piomelli, D
Publikováno v:
Mor, M; Lodola, A; Rivara, S; Vacondio, F; Duranti, A; Tontini, A; et al.(2009). Erratum: Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: Modulation at the N-portion of biphenyl-3-yl alkylcarbamates (Journal of Medicinal Chemistry (2008) 51 (3487)). Journal of Medicinal Chemistry, 52(1), 224. doi: 10.1021/jm801482q. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0gg961c3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::d24bb617a70438857e39cf65648e7fac
http://www.escholarship.org/uc/item/0gg961c3
http://www.escholarship.org/uc/item/0gg961c3
Publikováno v:
Clapper, JR; Mangieri, RA; & Piomelli, D. (2009). The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology, 56(SUPPL. 1), 235-243. doi: 10.1016/j.neuropharm.2008.07.018. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/5pm5574n
The endocannabinoid system modulates neurotransmission at inhibitory and excitatory synapses in brain regions relevant to the regulation of pain, emotion, motivation, and cognition. This signaling system is engaged by the active component of cannabis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::035e385f300aced43509352480608f53
http://www.escholarship.org/uc/item/5pm5574n
http://www.escholarship.org/uc/item/5pm5574n
Autor:
Justinova, Z, Mangieri, RA, Bortolato, M, Chefer, SI, Mukhin, AG, Clapper, JR, King, AR, Redhi, GH, Yasar, S, Piomelli, D, Goldberg, SR
Publikováno v:
Justinova, Z; Mangieri, RA; Bortolato, M; Chefer, SI; Mukhin, AG; Clapper, JR; et al.(2008). Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates. Biological Psychiatry, 64(11), 930-937. doi: 10.1016/j.biopsych.2008.08.008. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0pq080ms
Background: CB1cannabinoid receptors in the brain are known to participate in the regulation of reward-based behaviors. However, the contribution of each of the endocannabinoid transmitters, anandamide and 2-arachidonoylglycerol (2-AG), to these beha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::5a6e659def6ee81578223004131df214
http://www.escholarship.org/uc/item/0pq080ms
http://www.escholarship.org/uc/item/0pq080ms
Publikováno v:
U.S. News & World Report; 5/23/2005, Vol. 138 Issue 19, p20-20, 1/3p
Autor:
Clapper Jr., James R.
Publikováno v:
GeoIntelligence; Jan/Feb2006, p30-30, 1p
Autor:
Clapper JR; Abide Therapeutics, San Diego, California., Henry CL; Abide Therapeutics, San Diego, California., Niphakis MJ; Abide Therapeutics, San Diego, California., Knize AM; Abide Therapeutics, San Diego, California., Coppola AR; Abide Therapeutics, San Diego, California., Simon GM; Abide Therapeutics, San Diego, California., Ngo N; Abide Therapeutics, San Diego, California., Herbst RA; Abide Therapeutics, San Diego, California., Herbst DM; Abide Therapeutics, San Diego, California., Reed AW; Abide Therapeutics, San Diego, California., Cisar JS; Abide Therapeutics, San Diego, California., Weber OD; Abide Therapeutics, San Diego, California., Viader A; Abide Therapeutics, San Diego, California., Alexander JP; Abide Therapeutics, San Diego, California., Cunningham ML; Abide Therapeutics, San Diego, California., Jones TK; Abide Therapeutics, San Diego, California., Fraser IP; Abide Therapeutics, San Diego, California., Grice CA; Abide Therapeutics, San Diego, California., Ezekowitz RAB; Abide Therapeutics, San Diego, California., O'Neill GP; Abide Therapeutics, San Diego, California., Blankman JL; Abide Therapeutics, San Diego, California jackie@abidetx.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2018 Dec; Vol. 367 (3), pp. 494-508. Date of Electronic Publication: 2018 Oct 10.
Autor:
Cisar JS; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., Weber OD; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., Clapper JR; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., Blankman JL; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., Henry CL; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., Simon GM; Vividion Therapeutics , 3565 General Atomics Court, Suite 100 , San Diego , California 92121 , United States., Alexander JP; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., Jones TK; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., Ezekowitz RAB; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., O'Neill GP; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States., Grice CA; Abide Therapeutics , 10835 Road to the Cure, Suite 250 , San Diego , California 92121 , United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2018 Oct 25; Vol. 61 (20), pp. 9062-9084. Date of Electronic Publication: 2018 Aug 23.